To require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Prescription Drug Supply Chain Pricing Transparency Act. S. 3751. 119th
Cong., 2nd
sess., Introduced in Senate January 29, 2026. https://www.govinfo.gov/app/details/BILLS-119s3751is.
APA
Congress, Senate (2026, January 29). Prescription Drug Supply Chain Pricing Transparency Act (S. 3751 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s3751is.
MLA
United States, Congress, Senate. Prescription Drug Supply Chain Pricing Transparency Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s3751is. 119th Congress, S. 3751, Introduced in Senate 29 Jan. 2026.
Bluebook
S.3751 - 119th Congress (2025-2026): Prescription Drug Supply Chain Pricing Transparency Act, S.3751, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119s3751is.
